Pacira Pharmaceuticals Stock Trading Halted; FDA Advisory Committee to Review sNDA for EXPAREL® as a Nerve Block for Regional Analgesia

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. MU
4. SPY
5. ACN
6. IBM
7. META
8. PFE
9. TSLA
10. DPZ

Go back to Pacira Pharmaceuticals Stock Trading Halted; FDA Advisory Committee to Review sNDA for EXPAREL® as a Nerve Block for Regional Analgesia
PACIRA (NASDAQ: PCRX) Delayed: 23.37 +0.66 (2.91%)
Previous Close $22.71    52 Week High $80.25 
Open $22.90    52 Week Low $30.25 
Day High $23.40    P/E N/A 
Day Low $22.81    EPS $-2.08 
Volume 101,833       

PACIRA (NASDAQ: PCRX) Delayed: 23.37 +0.66 (2.91%)
Previous Close $22.71    52 Week High $80.25 
Open $22.90    52 Week Low $30.25 
Day High $23.40    P/E N/A 
Day Low $22.81    EPS $-2.08 
Volume 101,833